Remdesivir Priced At More Than $3,100 For A Course Of Treatment

Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected.

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

(Image credit: ULRICH PERREY/POOL/AFP via Getty Images)



from News : NPR https://www.npr.org/sections/health-shots/2020/06/29/884648842/remdesivir-priced-at-more-than-3-100-for-a-course-of-treatment?utm_medium=RSS&utm_campaign=news

Post a Comment

أحدث أقدم